Beyond Basics in Atopic Dermatitis Care: Are You Behind the Curve With Advanced Biologics for Moderate to Severe Disease?

Gain strategies in evaluating patient eligibility and implementing treatment plans using IL-4/IL-13–targeting or IL-13–targeting therapies for moderate to severe atopic dermatitis, through expert-written ClinicalThought commentaries, downloadable slides, an on-demand webcast, a downloadable resource, and an Interactive Decision Support Tool.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, LLC and the National Eczema Association.

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

National Eczema Association

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner